Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Prospective Study to Evaluate the Safety and Potential Efficacy of Single, Increasing Doses of TG100-115 in Subjects Undergoing Percutaneous Coronary Intervention for Acute Anterior ST Elevation Myocardial Infarction

NCT00103350 is registered in ClinicalTrials.gov with TargeGen as lead sponsor.

NCT NCT00103350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Prospective Study to Evaluate the Safety and Potential Efficacy of Single, Increasing Doses of TG100-115 in Subjects Undergoing Percutaneous Coronary Intervention for Acute Anterior ST Elevation Myocardial Infarction
Lead sponsor
TargeGen
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2005
Completion date
January 31, 2008
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction